Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

NCT00544700 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
265
Enrollment
OTHER
Sponsor class

Stopped Data collection is completed. As no changes in the endpoints were expected in the future, no further data is needed.

Conditions

Interventions

Sponsor

Swiss Cancer Institute